Edward Mezerhane, MD
Sleep Medicine · Miami, FLNPI 1063654218
Payments from drug & device makers
Across 1,327 payments — averaging $1455.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$813K
- Livanova USA, Inc.$447K
- Harmony Biosciences LLC$171K
- Avadel CNS Pharmaceuticals, LLC$161K
- Alkermes, Inc.$150K
- Lilly USA, LLC$64K
- plus $126K from 17 others
What the payments were for
- Consulting fees$108,16820%
- Speaking & faculty fees$368,52069%
- Travel & lodging$40,5378%
- Food & beverage$19,8724%
- Education$2320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 679 | $812,672 |
| Livanova USA, Inc. | 84 | $446,947 |
| Harmony Biosciences LLC | 136 | $171,128 |
| Avadel CNS Pharmaceuticals, LLC | 42 | $161,019 |
| Alkermes, Inc. | 132 | $149,628 |
| Lilly USA, LLC | 87 | $64,384 |
| Axsome Therapeutics, Inc. | 31 | $31,379 |
| Vanda Pharmaceuticals Inc. | 9 | $30,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $23,756 |
| Idorsia Pharmaceuticals US Inc | 29 | $16,492 |
| Eisai Inc. | 37 | $11,466 |
| Bayer | 2 | $4,600 |
| Zevra Therapeutics Inc | 1 | $3,638 |
| Eli Lilly | 3 | $2,700 |
| Inspire Medical Systems, Inc. | 4 | $666 |
| Fisher & Paykel Healthcare Inc | 10 | $578 |
| Resmed Corp | 8 | $192 |
| Medtronic(2 entities) | 2 | $149 |
| GSK | 1 | $115 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $112 |
| Arbor Pharmaceuticals, Inc. | 3 | $48 |
| Azurity Pharmaceuticals, Inc. | 2 | $43 |
| Itamar Medical Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,931,729 in reported general payments places this provider in the 95th percentile of 77 sleep medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 13 | $367 |
| Clonazepam | 20 | $301 |
| Trazodone Hcl | 26 | $127 |
| Ropinirole Hcl | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Miami
- Timothy GrantMiami$711K
- Harneet WaliaMiami$369K
- Alberto RamosMiami$129K
- Sergio JaramilloMiami$115K
- Carlos Ramirez MejiaMiami$25K
- Rosa GarciaMiami$3K
- Ghaith ShukriMiami$2K
- Salim DibMiami$2K
- Dionne MorganMiami$797
- Jeremy McConnellBradenton$615K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.